Home » Topics » BioWorld Science

BioWorld Science
RSS

Dimethaid Research announces encouraging results with its immunomodulator

May 31, 1996

LL-95509 exhibits optimum activity against GARFT

May 31, 1996

Meningococcal protein with vaccine potential

May 31, 1996

LJP-394 marketing agreement between La Jolla Pharma and Leo Denmark discontinued

May 31, 1996

Ruthenium complexes revealed by Procept

May 31, 1996

Zeneca claims prostaglandin E antagonists

May 31, 1996

Merck Frosst Canada reveals cyclooxygenase type 2 (COX-2) inhibitors

May 31, 1996

Di-tert-butylphenol compounds from Proctor & Gamble

May 31, 1996

Unimed announces licensing agreement on its testosterone products

May 31, 1996

NSC-645793 and NSC-651016: Anti-HIV agents with potential as clinical candidates

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.